Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hexabrix 320R for C.T. (computed tomography)--patient tolerance and image quality.

J G Stuckey1, R H James

  • 1Victorian Imaging Group, Dingley Victoria.

Australasian Radiology
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Legal aspects relating to the response of Defence Medical Services to a mass casualty event.

BMJ military health·2023
Same author

Stability of dissolved and soluble Fe(II) in shelf sediment pore waters and release to an oxic water column.

Biogeochemistry·2020
Same author

Analytical methods for determination of selected principal organic hazardous constituents in combustion products.

Environmental science & technology·2011
Same author

Indirect ophthalmoscopes: evaluation for potential hazard.

Applied optics·2010
Same author

Handheld ophthalmoscopes for hazards analysis: an evaluation.

Applied optics·2010
Same author

High accuracy laser power measurements: a scale comparison.

Applied optics·2010
Same journal

Percutaneous biliary internal decompression in a patient with simultaneous malignant biliary and duodenal obstruction and surgically modified anatomy.

Australasian radiology·2008
Same journal

Fluoromethylcholine PET in recurrent multifocal hepatoma.

Australasian radiology·2008
Same journal

Patent urachus in a neonate: findings at micturating cystourethregram.

Australasian radiology·2008
Same journal

Combined treatment of ablative therapy with percutaneous radiofrequency and cementoplasty of a symptomatic metastatic lesion of the acetabulum.

Australasian radiology·2007
Same journal

Basilar artery aneurysm treated with coil embolization via persistent primitive hypoglossal artery.

Australasian radiology·2007
Same journal

Emergency embolization of multiple splenic artery pseudoaneurysms associated with portal hypertension complicating cystic fibrosis.

Australasian radiology·2007
See all related articles

Hexabrix 320, an intravenous contrast agent for CT scans, demonstrated good image quality and was well-tolerated by patients, including the elderly and high-risk groups, with no severe adverse events reported.

Area of Science:

  • Radiology and Imaging
  • Medical Contrast Agents

Background:

  • Intravenous contrast materials are essential for CT scanning.
  • Assessing the safety and tolerability of contrast agents is crucial, especially in vulnerable patient populations.

Purpose of the Study:

  • To evaluate the safety and tolerability of Hexabrix 320 as an intravenous contrast agent.
  • To analyze adverse events in relation to patient age and risk category during CT scans.

Main Methods:

  • A study involving 367 patients undergoing CT scans with Hexabrix 320.
  • Systematic recording and analysis of adverse events.
  • Stratification of patients by age and risk category.

Main Results:

  • Hexabrix 320 provided adequate image quality in all 367 patients.

Related Experiment Videos

  • Minor adverse events were common, but moderate events were infrequent.
  • No severe adverse events were observed during the study.
  • The contrast agent was well-tolerated in elderly patients and those in high-risk categories.
  • Conclusions:

    • Hexabrix 320 is a safe and well-tolerated intravenous contrast agent for CT scanning.
    • Its safety profile is favorable, even in elderly and high-risk patient groups.
    • The agent effectively produces adequate image quality with a low incidence of severe adverse events.